COPD Clinical Trials

Showing 1601-1620 of 1,730 trials

US Biologic Lung Volume Reduction (BLVR) Phase 2 Emphysema Study

NCT00515164

The purpose of this study it to evaluate the efficacy and safety of the 20 mL BLVR System in patients with advanced upper lobe predominant emphysema.

Pulmonary EmphysemaChronic Obstructive Pulmonary Disease

Aeris Therapeutics22 participantsStarted Aug 2007

Phoenix, Arizona, United States • Iowa City, Iowa, United States • Topeka, Kansas, United States +5 more locations

COMPLETEDNA

Activity of Inspiratory Muscles With the Use of Positive Pressure in Patients With Chronic Obstructive Pulmonary Disease

NCT01111487

The objective is to evaluate whether the use of expiratory positive airway pressure (EPAP) reduces the electrical activity of the sternocleidomastoid muscle and enhances the action of the muscle in the patient parasternal ported from Chronic Obstructive Pulmonary Disease. Noting also, if the set pressure level (10 or 15 cmH2O) affects this relationship.

Chronic Obstructive Pulmonary Disease (COPD)

Hospital de Clinicas de Porto Alegre40 participantsStarted Nov 2009

Porto Alegre, Rio Grande do Sul, Brazil • Porto Alegre, Rio Grande do Sul, Brazil • Santa Cruz do Sul, Rio Grande do Sul, Brazil

US Biologic Lung Volume Reduction (BLVR) Phase 2 Emphysema Study

Activity of Inspiratory Muscles With the Use of Positive Pressure in Patients With Chronic Obstructive Pulmonary Disease

Related Searches

Study to Determine the Onset of Action of Indacaterol in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)

Continuous Positive Airway Pressure Versus Noninvasive Ventilation in Patients With Overlap Syndrome

An Exploratory Study, to Assess the Effect of Repeat-dose Inhaled Indacaterol Maleate (300 μg) on Dynamic and Static Lung Hyperinflation, Subjective Breathlessness and Health Status in Patients With Chronic Obstructive Pulmonary Disease(COPD)

Efficacy and Safety of Indacaterol Plus Tiotropium Versus Tiotropium Alone in Patients With Chronic Obstructive Pulmonary Disease

Safety, Tolerability and Efficacy of Indacaterol in Patients With Moderate-to-severe Chronic Obstructive Pulmonary Disease (COPD)

A Study to Compare the Lung Effect of Indacaterol and Tiotropium in Chronic Obstructive Pulmonary Disease (COPD)

ALK27-001: A Study of Trospium Inhalation Powder (TrIP)Administered to Subjects With COPD

12-week Efficacy of Indacaterol

Efficacy and Safety of Indacaterol Plus Tiotropium Versus Tiotropium Alone in Patients With Chronic Obstructive Pulmonary Disease

AZD2115 Single Ascending Dose Study

Efficacy and Safety of Indacaterol in Patients With Chronic Obstructive Pulmonary Disease (COPD) Using Salmeterol as Active Control

Efficacy, Safety, and Tolerability of Once Daily Indacaterol in Chronic Obstructive Pulmonary Disease (COPD) Using Formoterol Twice Daily as Active Control

Confirmatory Study of Indacaterol in Patients With Chronic Obstructive Pulmonary Disease (COPD)

A Crossover Study to Determine the Effect on Lung Function of Indacaterol in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD), Using Tiotropium as an Active Control

The Effect of Indacaterol on Exercise Endurance in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease

Study of Indacaterol Dosed in the Evening in Patients With Chronic Obstructive Pulmonary Disease (COPD)

Impact of Morning Symptoms in Clinical Control of Chronic Obstructive Pulmonary Disease (COPD)

Treatment With AKL1 in Obstructive Airways Disease (The TAKL Study)